Proceedings of the Standing Senate Committee on
Legal and Constitutional Affairs
Issue No. 10 - Minutes of Proceedings - June 9, 2016
OTTAWA, Thursday, June 9, 2016
(27)
[English]
The Standing Senate Committee on Legal and Constitutional Affairs met this day at 10:31 a.m., in room 257, East Block, the chair, the Honourable Bob Runciman, presiding.
Members of the committee present: The Honourable Senators Baker, P.C., Batters, Boisvenu, Carignan, P.C., Dagenais, Harder, P.C., Jaffer, Joyal, P.C., McIntyre, Plett, Runciman and White (12).
Other senators present: The Honourable Senators Fraser and Lankin, P.C. (2).
In attendance: Julian Walker and Maxime Charron-Tousignant, Analysts, Parliamentary Information and Research Services, Library of Parliament.
Also present: The official reporters of the Senate.
Pursuant to the order of reference adopted by the Senate on Thursday, May 19, 2016, the committee began its consideration of Bill S-1001, An Act to authorize La Capitale Financial Security Insurance Company to apply to be continued as a body corporate under the laws of the Province of Quebec.
WITNESSES:
La Capitale Financial Group Inc.:
Pierre Marc Bellavance, Vice President, Legal Affairs and Corporate Secretary;
Julie Noël de Tilly, Lawyer and Corporate Secretary Coordinator.
The chair made a statement.
Mr. Bellavance made a statement and, together with Ms. de Tilly, answered questions.
The committee took note of the statements of the Honourable Senators Joyal, P.C. and Fraser that they will not participate in debate on Bill S-1001.
It was agreed that the committee proceed to clause-by-clause consideration of Bill S-1001, An Act to authorize La Capitale Financial Security Insurance Company to apply to be continued as a body corporate under the lasw of the Province of Quebec.
It was agreed that the title stand postponed.
It was agreed that the preamble stand postponed.
It was agreed that clause 1 carry.
It was agreed that clause 2 carry.
It was agreed that the preamble carry.
It was agreed that the title carry.
It was agreed that the bill carry.
It was agreed that the chair report the bill to the Senate.
At 10:59 a.m., the committee suspended.
At 11:05 a.m., the committee resumed and, pursuant to the order of reference adopted by the Senate on Thursday, May 12, 2016, the committee continued its consideration of Bill S-225, An Act to amend the Controlled Drugs and Substances Act (substances used in the production of fentanyl).
WITNESSES:
The Honourable Senator Vernon White, sponsor of the bill.
Health Canada:
Kirsten Mattison, Director, Office of Drug Policy, Controlled Substances Directorate;
Norma Won, Legal Counsel;
Jacqueline Gonçalves, Director General, Controlled Substances Directorate.
The Honourable Vernon White made a statement and answered questions.
Ms. Mattison made a statement and, together with Ms. Won and Ms. Gonçalves, answered questions.
It was agreed that the committee proceed to clause-by-clause consideration of Bill S-225, An Act to amend the Controlled Drugs and Substances Act (substances used in the production of fentanyl).
It was agreed that the title stand postponed.
The chair asked whether clause 1 shall carry.
The Honourable Senator Harder, P.C., moved that Bill S-225, in clause 1, be amended by replacing lines 8 to 10 on page 1 with the following:
26 1-Phenethyl-4-piperidone and its salts
27 4-Piperidone and its salts
28 Norfentanyl (N-phenyl-N-piperidin-4-ylpropanamide) and its salts
29 1-Phenethylpiperidin-4-ylidenephenylamine and its salts
30 N-Phenyl-4-piperidinamine and its salts
After debate, the question being put on the motion it was adopted.
It was agreed that clause 1, as amended, carry.
It was agreed that the title carry.
It was agreed that the bill, as amended, carry.
The chair asked whether the committee wished to append observations to the report on the bill.
The Honourable Senator Jaffer moved that two observations be appended to the report. One to encourage that the Minister, with this bill, move on a national educational campaign on the use of fentanyl and the second one is the issue of timelines.
It was agreed that the analysts draft observations on those lines to be appended to the report.
It was agreed that the chair report the bill, as amended, with observations, to the Senate.
The chair informed members that Senator Jaffer was resigning from the position of deputy chair of the committee.
The committee proceeded to the election of a new deputy chair.
The Honourable Senator Jaffer moved that the Honourable Senator Baker, P.C. be deputy chair of this committee.
The question being put on the motion, it was adopted.
At 12:28 p.m., the committee adjourned to the call of the chair.
ATTEST:
La greffière du comité,
Jessica Richardson